1. Q5A(R2): viral safety evaluation of biotechnology products derived from cell lines of human or animal origin : guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, January 2024 Subject(s): BiotechnologyCell LineDrug IndustryGovernment RegulationSafetyVirus DiseasesUnited States
